ARTICLE | Clinical News
Brintellix vortioxetine regulatory update
February 8, 2016 8:00 AM UTC
FDA’s Psychopharmacologic Drugs Advisory Committee voted 8-2 that Brintellix vortioxetine from Takeda and H. Lundbeck provided substantial evidence to support an efficacy claim for Brintellix vortioxe...